Department of Neurosurgery, Bongseng memorial hospital, Busan, the Republic of Korea.
Department of Neurology, Biomedical Research Institute, Pusan National University Hospital, School of Medicine, Pusan National University, Busan, the Republic of Korea.
Clin Neurol Neurosurg. 2023 Jul;230:107777. doi: 10.1016/j.clineuro.2023.107777. Epub 2023 May 8.
Overlapping stenting is sometimes attempted during endovascular treatment of cerebral aneurysm as a rescue for coil herniation, stent mal-positioning, or in-stent thrombosis. We retrospectively evaluated the efficacy and safety of additional rescue stenting (ARS) in telescoping fashion with Neuroform Atlas stent (NAS) during stent-assisted coiling of saccular aneurysms.
We collected clinical and radiological data of patients with saccular aneurysms treated with ARS using NASs between March 2018 and December 2021. Y or X-stent-assisted coiling technique was excluded.
Eighteen unruptured and 5 ruptured aneurysms in 23 patients were treated with ARS using NASs. Sizes of aneurysms ranged from 2.0 mm to 10.0 mm (mean: 5.0 mm). Immediate angiographic results were complete occlusion in 11 aneurysms, residual neck in 4 aneurysms, and residual sac in 8 aneurysms. Peri-operative morbidity was 4.3 %. Nineteen of 23 patients underwent follow-up conventional angiography (mean, 9.9 months). Results showed progressive occlusion in 10 (52.6 %) cases and asymptomatic in-stent stenosis in 3 (15.8 %) cases. At the end of the observation period (mean, 17.4 months), all 18 patients without subarachnoid hemorrhage had excellent clinical outcomes (mRS of 0), except one (mRS of 1). Of five patients with subarachnoid hemorrhage, four had a favorable outcome (mRS of 0-1), while the other one was dependent (mRS of 4).
In this report on 23 patients, ARS with NASs for treating saccular aneurysms showed good technical safety with favorable clinical and angiographic outcomes. However, delayed in-stent stenosis was not uncommon. Thus, regular imaging follow-up is required.
在颅内动脉瘤的血管内治疗中,有时会尝试重叠支架置入术,以挽救线圈突出、支架位置不当或支架内血栓形成。我们回顾性评估了在支架辅助弹簧圈栓塞治疗囊状动脉瘤时,使用 Neuroform Atlas 支架(NAS)进行伸缩式附加救援支架置入术(ARS)的疗效和安全性。
我们收集了 2018 年 3 月至 2021 年 12 月期间使用 NAS 进行 ARS 治疗的囊状动脉瘤患者的临床和影像学资料。排除 Y 或 X 支架辅助弹簧圈栓塞技术。
23 例患者的 18 个未破裂和 5 个破裂动脉瘤采用 NAS 进行 ARS 治疗。动脉瘤大小为 2.0-10.0mm(平均 5.0mm)。即刻血管造影结果为 11 个动脉瘤完全闭塞,4 个动脉瘤残留瘤颈,8 个动脉瘤残留瘤腔。围手术期并发症发生率为 4.3%。23 例患者中有 19 例行随访常规血管造影(平均时间 9.9 个月)。结果显示 10 例(52.6%)动脉瘤进行性闭塞,3 例(15.8%)无症状支架内狭窄。在观察期结束时(平均 17.4 个月),所有 18 例无蛛网膜下腔出血的患者均有良好的临床结局(mRS 为 0),除 1 例外(mRS 为 1)。5 例蛛网膜下腔出血患者中,4 例预后良好(mRS 为 0-1),另 1 例依赖(mRS 为 4)。
在这项 23 例患者的报告中,使用 NAS 进行 ARS 治疗囊状动脉瘤具有良好的技术安全性,临床和血管造影结局良好。然而,支架内迟发性狭窄并不少见,因此需要定期影像学随访。